Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program

This study (CABOREAL) reports treatment patterns and outcomes for patients treated with cabozantinib through the French Early Access Program.

Source: European Journal of Cancer - November 27, 2020 Category: Cancer & Oncology Authors: Laurence Albiges, Aude Fl échon, Christine Chevreau, Delphine Topart, Gwenaëlle Gravis, Stéphane Oudard, Jean M. Tourani, Lionnel Geoffrois, Emeline Meriaux, Antoine Thiery-Vuillemin, Philippe Barthélémy, Sylvain Ladoire, Brigitte Laguerre, Valérie Tags: Original Research Source Type: research